Angiogenesis after acute myocardial infarction
X Wu, MR Reboll, M Korf-Klingebiel… - Cardiovascular …, 2021 - academic.oup.com
Acute myocardial infarction (MI) inflicts massive injury to the coronary microcirculation
leading to vascular disintegration and capillary rarefication in the infarct region. Tissue …
leading to vascular disintegration and capillary rarefication in the infarct region. Tissue …
[HTML][HTML] Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control
X Chang, A Lochner, HH Wang, S Wang, H Zhu… - Theranostics, 2021 - ncbi.nlm.nih.gov
Endothelial cells (ECs) constitute the innermost layer in all blood vessels to maintain the
structural integrity and microcirculation function for coronary microvasculature. Impaired …
structural integrity and microcirculation function for coronary microvasculature. Impaired …
Small animal models of heart failure
C Riehle, J Bauersachs - Cardiovascular research, 2019 - academic.oup.com
Heart disease is a major cause of death worldwide with increasing prevalence, which urges
the development of new therapeutic strategies. Over the last few decades, numerous small …
the development of new therapeutic strategies. Over the last few decades, numerous small …
Coronary microvascular obstruction: the new frontier in cardioprotection
G Heusch - Basic Research in Cardiology, 2019 - Springer
Cardioprotection aims at infarct size reduction and improvement of clinical outcome from
myocardial infarction. The translation of cardioprotection from preclinical and promising …
myocardial infarction. The translation of cardioprotection from preclinical and promising …
[HTML][HTML] IMproving preclinical assessment of cardioprotective therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST action
Acute myocardial infarction (AMI) and the heart failure (HF) which may follow are among the
leading causes of death and disability worldwide. As such, new therapeutic interventions are …
leading causes of death and disability worldwide. As such, new therapeutic interventions are …
M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment
S Liu, J Chen, J Shi, W Zhou, L Wang, W Fang… - Basic research in …, 2020 - Springer
The roles and the underlying mechanisms of M1-type macrophages in angiogenesis and
postmyocardial infarction (MI) cardiac repair have remained unclear. In this study, we …
postmyocardial infarction (MI) cardiac repair have remained unclear. In this study, we …
Optimized treatment of ST-elevation myocardial infarction: the unmet need to target coronary microvascular obstruction as primary treatment goal to further improve …
Primary percutaneous coronary intervention is nowadays the preferred reperfusion strategy
for patients with acute ST-segment–elevation myocardial infarction, aiming at restoring …
for patients with acute ST-segment–elevation myocardial infarction, aiming at restoring …
Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction
LSF Konijnenberg, P Damman… - Cardiovascular …, 2020 - academic.oup.com
Early mechanical reperfusion of the epicardial coronary artery by primary percutaneous
coronary intervention (PCI) is the guideline-recommended treatment for ST-elevation …
coronary intervention (PCI) is the guideline-recommended treatment for ST-elevation …
[HTML][HTML] Protective effect of HINT2 on mitochondrial function via repressing MCU complex activation attenuates cardiac microvascular ischemia–reperfusion injury
S Li, J Chen, M Liu, Y Chen, Y Wu, Q Li, T Ma… - Basic research in …, 2021 - Springer
Current evidence indicates that coronary microcirculation is a key target for protecting
against cardiac ischemia–reperfusion (I/R) injury. Mitochondrial calcium uniporter (MCU) …
against cardiac ischemia–reperfusion (I/R) injury. Mitochondrial calcium uniporter (MCU) …
[HTML][HTML] Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology
E Józefczuk, TJ Guzik, M Siedlinski - Pharmacological research, 2020 - Elsevier
Abstract Sphingosine-1-phosphate (S1P) is a signaling lipid, synthetized by sphingosine
kinases (SPHK1 and SPHK2), that affects cardiovascular function in various ways. S1P …
kinases (SPHK1 and SPHK2), that affects cardiovascular function in various ways. S1P …